Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms
about
Nucleic acid targeting: towards personalized therapy for head and neck cancer.Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy.Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma.JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth.Gene therapy for cancer: present status and future perspectiveSystemic therapy strategies for head-neck carcinomas: Current statusUtility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapyTherapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.The current state of head and neck cancer gene therapy.Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.New advances in molecular approaches to head and neck squamous cell carcinoma.Chapter seven--Cancer treatment with gene therapy and radiation therapy.Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck.Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer.Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancerNew strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors.Quantitative analysis of survivin protein expression and its therapeutic depletion by an antisense oligonucleotide in human lung tumors.Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors.EGFR-targeted therapies in the post-genomic era.Emerging drugs for head and neck cancer.
P2860
Q26850237-C785525F-3AD2-425D-8A61-D9988402E5E9Q30446500-6025B436-3FFE-4215-88FF-4F1787A32EEBQ33976619-F0753E51-0C5C-4AD3-8765-EA9A8324B489Q34618994-C8E25EF2-1827-493C-92B0-3E0F7BB2F8CFQ35214530-7865340A-65C7-43E9-994B-BCF13E48A26CQ35673900-D4A64404-AB3D-4F84-97F9-A2E8489F4B8AQ36529843-7CBCCAF9-83C6-4006-AD5D-1E7FC3B7C8B8Q36533822-2C86CAA9-ECB2-4ABE-91EF-8337A4B8B2DDQ36890491-BC2222EA-98E3-40E3-BFAD-5647A114E903Q37295261-487F6443-30FC-416A-A035-59D097487487Q37562093-7236F5C5-4831-4473-8B62-312357E6BE55Q37595513-56241B56-ACA9-49A5-BC19-732F0E20442AQ37736496-B8FC0375-FED3-4EA4-9AD9-3F9194B40A20Q37823161-2E262FE0-F3C7-4467-B07E-6EA02E80E5F3Q38047477-0993CF80-E177-4BFB-B4CC-B9CE549AA488Q38320343-F73A85DE-E393-4E0E-BC0D-A41EB485036FQ38892486-DECCBE91-87B8-4758-BEE7-FA4F685004B3Q39709920-A1317E83-2B3B-40E4-9C5A-83969BFD8CBBQ39730112-79EFB1EE-E565-4ACB-9DC4-5A4E31A5732DQ41127315-6492F178-F023-47CF-B42F-79F963A3E47BQ42129596-EF88586F-A361-4C6C-AADD-7C538CF86FCCQ42545098-1E3CD7D1-A678-4D6E-966F-A86673C2BD1CQ45871491-01628935-4C5D-461D-80C1-C4294861D417Q45874449-FBF6D413-4613-49FE-8994-5BA193E9D04A
P2860
Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intratumoral epidermal growth ...... potential antitumor mechanisms
@en
Intratumoral epidermal growth ...... otential antitumor mechanisms.
@nl
type
label
Intratumoral epidermal growth ...... potential antitumor mechanisms
@en
Intratumoral epidermal growth ...... otential antitumor mechanisms.
@nl
prefLabel
Intratumoral epidermal growth ...... potential antitumor mechanisms
@en
Intratumoral epidermal growth ...... otential antitumor mechanisms.
@nl
P2093
P2860
P356
P1476
Intratumoral epidermal growth ...... potential antitumor mechanisms
@en
P2093
Ann Marie Egloff
Ashok Muthukrishnan
Athanassios Argiris
Barton F Branstetter
Dong M Shin
Erin E Childs
Eugene N Myers
Gordon Mills
James M Mountz
Jonas T Johnson
P2860
P304
P356
10.1200/JCO.2008.17.8251
P407
P577
2009-02-09T00:00:00Z